An investigation of the efficacy of a cognitive behavioural treatment for patients with recent onset rheumatoid arthritis

ISRCTN ISRCTN98753115
DOI https://doi.org/10.1186/ISRCTN98753115
Secondary identifying numbers RDC00038
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
05/07/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Tom Sensky
Scientific

Imperial College School of Medicine
West Middlesex University Hospital
Isleworth
TW7 6AF
United Kingdom

Phone +44 (0)20 8565 2121
Email abc@123.com

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeQuality of life
Scientific titleAn investigation of the efficacy of a cognitive behavioural treatment for patients with recent onset rheumatoid arthritis
Study objectivesThe present study will aim to investigate the efficacy of a cognitive behavioural intervention for patients with recent onset Rheumatoid Arthritis (RA). Research has clearly demonstrated that cognitive-behavioural treatments are successful in treating patients with RA, but much of the research to date has been with people with a long history of active disease. This is clinically important since earlier intervention might prevent psychologically and/or physical morbidity.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedRheumatoid arthritis
Intervention1. Individual course of cognitive-behavioural therapy
2. Matched waiting list control group
Intervention typeOther
Primary outcome measure1. Coping Strategies Questionnaire
2. Percentage of subjects with clinically important depression or anxiety
3. Proportion of subjects with Eryhtrocyte Sedimentation Rate (ESR) of more than 30 mm/hr
4. Proportion of subjects with C-Reactive Protein (CRP) of more than 10 mg/l
Secondary outcome measuresNot provided at time of registration
Overall study start date30/05/1995
Completion date30/09/2000

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexBoth
Target number of participants40
Key inclusion criteria1. 40 patients recruited from the West Middlesex University Hospital Rheumatology Clinic
2. Age group 18-65
3. Definite or classic Rheumatoid Arthritis with onset of symptoms in the past two years
4. Active but stable on current medication
Key exclusion criteriaNot provided at time of registration
Date of first enrolment30/05/1995
Date of final enrolment30/09/2000

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Imperial College School of Medicine
Isleworth
TW7 6AF
United Kingdom

Sponsor information

NHS R&D Regional Programme Register - Department of Health (UK)
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.doh.gov.uk

Funders

Funder type

Government

NHS Executive London (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article initial results 01/01/2001 Yes No
Results article long-term efficacy results 01/03/2003 Yes No
Results article 5-year follow-up results 15/03/2008 Yes No

Editorial Notes

05/07/2018: Internal review